Journal article · 2020 · Open access
The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer
Patient Preference and Adherence, Volume 14, 2093–2104 · Published 1 October 2020 · DOI 10.2147/ppa.s248295
In brief
“The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer” is a 2020 journal article by Brett Hauber and 3 co-authors, published in Patient Preference and Adherence. OpenAlex counts 26 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Patient Preference and Adherence.
- Citations
- 26
- Most cited in
- 2025 (9)
- Field-weighted impact
- 1.39
- References
- 38
- Authors
- 4
Abstract
PURPOSE: Immuno-oncology treatments offer patients with advanced non-small cell lung cancer (NSCLC) treatment options with greater probability of durable survival and a different toxicity profile compared with traditional chemotherapy. The objective of this study was to explore the importance of increases in the probability of long-term survival versus changes in expected (median) survival and treatment toxicities among patients with advanced NSCLC and physicians. PATIENTS AND METHODS: In a discrete-choice experiment, oncologists and patients diagnosed with NSCLC chose between profiles of treatments for advanced NSCLC offering different combinations of benefits (expected, best-case, and worst-case survival) and risks. We analyzed preference data from each sample using a random-parameters logit model that controls for preference heterogeneity and the panel nature of the data. RESULTS: Both patients and physicians expressed a strong preference for improving the probability of best-case survival; however, patients viewed increases in the probability of long-term survival as more important than increases in expected survival, while the opposite was true for physicians. Both patients and physicians weighted survival to be more important than toxicities. CONCLUSION: This study identified a potentially important divergence between physician and patient perspectives on survival statistics. Physicians placed more importance on increases in expected survival than did patients with NSCLC. The importance patients placed on long-term survival reinforce previous research identifying the primacy of hope as a value among seriously ill patients. The findings underscore the importance of considering patients' priorities and in shared decision-making when choosing treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hauber, B., Penrod, J. R., Gebben, D., & Musallam, L. (2020). The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer. Patient Preference and Adherence, Volume 14, 2093–2104. https://doi.org/10.2147/ppa.s248295
MLA 9
Hauber, Brett, et al. “The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer.” Patient Preference and Adherence, vol. Volume 14, 2020, pp. 2093–2104. https://doi.org/10.2147/ppa.s248295.
Chicago
Hauber, Brett, John R. Penrod, David Gebben, and Lina Musallam. 2020. “The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer.” Patient Preference and Adherence Volume 14: 2093–2104. https://doi.org/10.2147/ppa.s248295.
Harvard
Hauber, B. et al. (2020) ‘The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer’, Patient Preference and Adherence, Volume 14, pp. 2093–2104. doi:10.2147/ppa.s248295.
IEEE
B. Hauber, J. R. Penrod, D. Gebben, and L. Musallam, “The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer,” Patient Preference and Adherence, vol. Volume 14, pp. 2093–2104, 2020, doi: 10.2147/ppa.s248295.
BibTeX
@article{hauber2020value,
title = {{The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer}},
author = {Hauber, Brett and Penrod, John R. and Gebben, David and Musallam, Lina},
journal = {Patient Preference and Adherence},
year = {2020},
volume = {Volume 14},
pages = {2093--2104},
doi = {10.2147/ppa.s248295},
url = {https://doi.org/10.2147/ppa.s248295}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2022 | 3 | |
| 2023 | 5 | |
| 2024 | 2 | |
| 2025 | 9 | |
| 2026 | 6 |
Its field-weighted citation impact is 1.39: it has been cited 1.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
- advanced non-small cell lung cancer
- patient preferences
- physician preferences
- survival probability
- treatment toxicity
- cancer immunotherapy
- shared decision-making
- hope
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Hauber, B., Penrod, J. R., Gebben, D., & Musallam, L. (2020). The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer. Patient Preference and Adherence, Volume 14, 2093–2104. https://doi.org/10.2147/ppa.s248295
How many times has this paper been cited?
26 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Patient Preference and Adherence: sign in and open the PDF from this page.
Who wrote this paper?
Brett Hauber, John R. Penrod, David Gebben, Lina Musallam.
What is the DOI of this paper?
10.2147/ppa.s248295, permanently at https://doi.org/10.2147/ppa.s248295. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.